FDA Clarifies Modification Process For Blood Products
The U.S. Food and Drug Administration on Friday released draft guidance to streamline the process for manufacturers of blood products like platelets modifying already-approved products, saying it wanted to clarify when...To view the full article, register now.
Already a subscriber? Click here to view full article